Squarepoint Ops LLC Apellis Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

  • $80.7 Billion
  • Q1 2025

A detailed history of Squarepoint Ops LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 442,793 shares of APLS stock, worth $8.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
442,793
Previous 166,962 165.21%
Holding current value
$8.67 Million
Previous $5.33 Million 81.77%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$21.87 - $34.63 $6.03 Million - $9.55 Million
275,831 Added 165.21%
442,793 $9.68 Million
Q4 2024

Feb 14, 2025
BUY
$26.18 - $35.42 $2.01 Million - $2.71 Million
76,621 Added 84.81%
166,962 $5.33 Million
Q3 2024

Nov 14, 2024
BUY
$28.84 - $41.15 $838,753 - $1.2 Million
29,083 Added 47.48%
90,341 $2.61 Million
Q2 2024

Aug 14, 2024
BUY
$38.07 - $59.71 $2.33 Million - $3.66 Million
61,258 New
61,258 $2.35 Million
Q3 2022

Nov 14, 2022
BUY
$44.76 - $69.66 $2.27 Million - $3.53 Million
50,705 Added 100.65%
101,085 $6.9 Million
Q2 2022

Aug 15, 2022
BUY
$35.07 - $59.21 $1.09 Million - $1.84 Million
31,082 Added 161.06%
50,380 $2.28 Million
Q1 2022

May 16, 2022
BUY
$35.46 - $54.12 $684,307 - $1.04 Million
19,298 New
19,298 $981,000
Q3 2021

Nov 15, 2021
SELL
$31.4 - $69.84 $167,801 - $373,224
-5,344 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$40.9 - $64.9 $218,569 - $346,825
5,344 New
5,344 $338,000
Q4 2020

Feb 16, 2021
SELL
$30.79 - $57.2 $813,533 - $1.51 Million
-26,422 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$25.89 - $33.65 $94,032 - $122,216
3,632 Added 15.94%
26,422 $797,000
Q2 2020

Aug 14, 2020
BUY
$24.8 - $38.49 $317,415 - $492,633
12,799 Added 128.11%
22,790 $744,000
Q1 2020

May 15, 2020
SELL
$17.91 - $44.33 $185,690 - $459,613
-10,368 Reduced 50.93%
9,991 $268,000
Q4 2019

Feb 14, 2020
SELL
$22.1 - $30.8 $520,189 - $724,970
-23,538 Reduced 53.62%
20,359 $623,000
Q3 2019

Nov 14, 2019
SELL
$24.09 - $32.18 $484,281 - $646,914
-20,103 Reduced 31.41%
43,897 $1.06 Million
Q2 2019

Aug 14, 2019
BUY
$18.0 - $25.34 $322,002 - $453,307
17,889 Added 38.8%
64,000 $1.62 Million
Q1 2019

May 15, 2019
BUY
$12.81 - $19.82 $41,081 - $63,562
3,207 Added 7.47%
46,111 $899,000
Q4 2018

Feb 14, 2019
BUY
$11.47 - $18.71 $250,091 - $407,952
21,804 Added 103.34%
42,904 $566,000
Q3 2018

Nov 14, 2018
BUY
$16.57 - $21.03 $349,627 - $443,733
21,100 New
21,100 $375,000

Others Institutions Holding APLS

# of Institutions
287
Shares Held
124M
Call Options Held
921K
Put Options Held
761K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.15B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email